In conclusion, our study demonstrates that AT effectively ameliorates hyperlipidemia, hepatic steatosis, insulin resistance, and atherosclerosis but has a null effect on PVAT abnormality or vascular dysfunction in lipodystrophic Seipin/Apoe dKO mice. The gene discussed is APOE; the disease is fatty liver disease.